ADD
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ADD Trademark

Serial Number: 97862513 • Registration: 8113181

ADD is a trademark filed by TATA CONSULTANCY SERVICES LIMITED on March 29, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

TATA CONSULTANCY SERVICES LIMITED (62 trademarks)

Nirmal Building, 9th Fl.
Maharashtra 400021 , IN

Entity Type: 11

Trademark Details

Filing Date

March 29, 2023

Registration Date

January 27, 2026

Published for Opposition

December 9, 2025

Goods & Services

Scientific research, study and research consultation in the fields of medicine, drug delivery, clinical trials, drug development; laboratory research in the field of new drug development; Design and development of computer software for pharmacovigilance, medicine, drug delivery, clinical trials, drug development, automate drug regulatory processes and compliance with drug registration; online non-downloadable computer software to provide aforementioned services using artificial intelligence and machine learning techniques; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Research and development of vaccines and medicines; Consultancy relating to quality control; Advisory services relating to all the aforesaid services; online non-downloadable computer software services for pharmacovigilance; scientific and technological services, namely, scientific and medical research in the fields of pharmaceutical, drug development, clinical trials, life sciences, and medical devices; Software as a Service (SaaS) featuring software for data collection, data management and data analytics, Platform as a Service (PaaS) featuring software for data collection, data management and data analytics in the fields of medicine, drug delivery, clinical trials, drug development, automate drug regulatory processes and compliance with drug registration; online non-downloadable computer software for data collection, data management and data analytics in the fields of medicine, drug delivery, clinical trials, drug development, automate drug regulatory processes and compliance with drug registration using artificial intelligence and machine learning techniques

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, drug development and applications for drug approval; Computerized file management includes data related to drug development, regulatory compliance, and pharmacovigilance

Downloadable computer software platform used for collecting and analyzing data in the field of healthcare and optimization of healthcare, clinical and hospital processes; downloadable computer software and downloadable computer firmware used for automating control of medical equipment; downloadable computer software for information management, data collection and data analysis of medical equipment, all of the above for pharmaceutical, life sciences, medical devices and healthcare providers; downloadable computer software for clinical trials and drug development; downloadable computer software for database analysis and management; computer hardware and downloadable software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; downloadable computer software platform for pharmacovigilance that enables automation of case processing and supports diverse data source formats; downloadable computer software to automate drug regulatory processes and compliance with drug registration; downloadable computer software for controlling and managing patient medical information

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 27, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 27, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2025 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 4, 2025 RCCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 9, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 3, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
May 3, 2025 GNSL
SUSPENSION LETTER WRITTEN
May 3, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 20, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 7, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 7, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 7, 2025 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 10, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 10, 2024 GNSL
SUSPENSION LETTER WRITTEN
Mar 10, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 25, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 16, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 16, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 16, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 21, 2023 DOCK
TEAS VOLUNTARY AMENDMENT RECEIVED
Oct 16, 2023 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 20, 2023 NWOS
NEW APPLICATION ENTERED
Apr 1, 2023 NWAP